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Background: Glial scar formation is a common histopathological feature of traumatic brain injury (TBI). Astrogliosis
and expression of transforming growth factor beta (TGF-β) are key components of scar formation and blood-brain
barrier modulation. Connective tissue growth factor (CTGF) is considered a cytokine mediating the effects of TGF-β.
Methods: Here, we studied the CTGF expression in an open-skull weight-drop-induced TBI, with a focus on the
early phase, most amenable to therapy.
Results: In normal rat brains of our study, CTGF+ cells were rarely observed. Significant parenchymal accumulation
of CTGF+ non-neuron cells was observed 72 h post-TBI and increased continuously during the investigating time.
We also observed that the accumulated CTGF+ non-neuron cells were mainly distributed in the perilesional areas
and showed activated astrocyte phenotypes with typical stellate morphologic characteristics.
Conclusion: Our observations demonstrated the time-dependent and lesion-associated accumulation of cellular
CTGF expression in TBI, suggesting a pathological role of CTGF in TBI.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/3963462091241165
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Glial scar formation is a common histopathological feature
of traumatic brain injury (TBI). It persists for long periods
and acts as barrier not only to axon regeneration but also
to inflammatory cells in a manner that protects healthy
tissue from nearby areas of intense inflammation [1].
Reactive astrocytosis is the key contributes to glial scar
formation [2]. Induced by stimuli from lesions, astro-
cytes enter into the injured zone, are activated, and play
a major role in the response to TBI. In central nervous
system (CNS) injuries, activated astrocytes secrete many
cytokines, among which transforming growth factor
(TGF)-β is regarded as one of the most potent cyto-
kines, it can be selectively upregulated in astrocytes and* Correspondence: zhangzhiren@yahoo.com
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unless otherwise stated.contribute to scar formation after injury through inducing
secretion of another “downstream mediator”, the cytokine
connective tissue growth factor (CTGF) [3,4].
CTGF is a secreted peptide encoded by an immediate
early growth responsive gene that has been shown to
be a downstream mediator of TGF-β1 action, induces
mitogenesis, chemotaxis, and cell matrix induction of
fibroblasts [5]. Due to these properties, CTGF plays
important roles in the regulation of scar formation, wound
healing, cell migration, proliferation and extracellular
matrix [4,6]. A series of studies has also demonstrated
that CTGF over-expression correlates with many fibrotic
and inflammation-associated diseases, such as fibrotic
skin disease, atherosclerosis and inflammatory bowel
disease [7-9].
Upregulation of CTGF has been observed in a variety
of nervous system-related disorders. In Alzheimer’s dis-
ease, CTGF was observed to overexpress in perivascularThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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indicating the role for CTGF in the process of chronic
neurodegeneration [10]. In amyotrophic lateral sclerosis,
CTGF was dramatically increased in reactive astrocytes
of the ventral horn, supporting a role for CTGF in the
molecular mechanisms underlying astrogliosis [11].
Although the expression of CTGF has been reported
in human TBI, mice spinal cord injury, and rat kainic
acid-induced brain injury, altered CTGF expression
following TBI models are not completely clear. There-
fore, in the current study, we have investigated the spatio-
temporal expression of CTGF following an open-skull
weight-drop-induced TBI in rat brains.
Methods
Animal experiments and tissue library
Brain libraries of normal and TBI rats have been described
previously [12]. In brief, male Lewis rats (8–9 weeks of
age, 350–400 g; Elevage Janvier, Le Genest-St-Isle, France)
were housed under equal daily periods of light and dark
and with free access to food and water. All procedures
were performed in accordance with the published Inter-
national Health Guidelines under a protocol approved
by the Administration District Official Committee. The
number of rats used and their suffering were minimized.
TBI was induced in anesthetized rats using an open-
skull weight-drop contusion model. Rats were grouped
randomly, anesthetized with Ketamine (120 mg/kg)/
Rompun (8 mg/kg), and subjected to craniotomy, in
which a circular region of the skull (3.0 mm diameter,
centered 2.3 mm caudal and 2.3 mm lateral to bregma)
was removed over the right somatosensory cortex. A
weight-drop device was placed over the dura and
adjusted to stop an impact transducer (foot plate) at a
depth of 2.5 mm below the dura. Then, a 20 g weight
was dropped from 15 cm above the dura, through a
guiding tube onto the foot plate. Body temperature was
maintained using an overhead heating lamp during
surgery. After injury, the scalp was closed tightly. Rats
with TBI survived without further treatment and were
euthanized at different time points (6, 12, 18, 24, 48,
72, and 96 h; 3–5 rats/time point).
For euthanasia, rats (26 TBI rats, five normal control
rats) were deeply anesthetized with Ketamine (120 mg/
kg)/Rompun (8 mg/kg) and perfused intracardially with
4°C 4% paraformaldehyde in PBS. Brains were quickly
removed and postfixed in 4% paraformaldehyde overnight
at 4°C. Fixed rat whole brains were placed in rodent brain
matrices (coronal) and were sliced to obtain the cortical
coronal blocks containing the contusion regions. These
cortical coronal blocks were embedded in paraffin, serially
sectioned (3 μm) through the center of the traumatized
area, and mounted on silan-covered slides. The con-
tused areas were numbered and during the subsequentimmunostaining, the same antibody was applied to sections
with the same number.
Immunohistochemistry
After dewaxing, brain sections were boiled (in an 850 W
microwave oven) for 15 min in citrate buffer (2.1 g
citric acid monohydrate/l, pH = 6) (Carl Roth, Karlsruhe,
Germany). Endogenous peroxidase was inhibited by 1%
H2O2 in pure methanol (Merck, Darmstadt, Germany)
for 15 min. Sections were incubated with 10% normal pig
serum (Biochrom, Berlin, Germany) to block nonspecific
binding of immunoglobulins and then with the poly-
clonal antibody CTGF (1:100, BMA; USbio, Swampscott,
Massachusetts, USA) overnight at 4°C. Antibody binding
to tissue sections was visualized with a biotinylated rabbit
anti-mouse IgG F(ab)2 antibody fragment (1 : 400; Dako,
Hamburg, Germany). Subsequently, sections were incu-
bated with a horseradish peroxidase-conjugated strepta-
vidin complex for 30 min (1: 100; Dako), followed by
development with diaminobenzidine substrate (Fluka,
Neu-Ulm, Germany). Finally, sections were counterstained
with Mayer’s hemalaun. As negative controls, the primary
antibodies were excluded.
Data acquisition and statistical analysis
After immunostaining, the brain sections of each time
point were examined by light microscopy. The numbers
of CTGF+ non-neuron cells were counted in eight non-
overlapping high-power fields (×400 magnification) for
each section. The high-power fields were selected to have
a maximum of positive cells. In each field studied, only
positive cells with the nucleus at the focal plane were
counted. Results were presented as arithmetic means of
CTGF+ non-neuron cells per high-power fields and SEM.
Statistical analysis was carried out using one-way analysis
of variance, followed by Dunnett’s multiple comparison
tests or a nonparametric t-test (GraphPad Prism 4.0
Software, San Diego, USA). For all statistical analyses,
significance levels were set at P value less than 0.05.
Results
A reproducible local lesion is formed on open-skull weight-
drop injury in the ipsilateral cortex. The development
of the lesion following TBI was analyzed using H&E
staining has been described previously [13]. In brief,
selective neuronal loss and necrotic loci condensed at
the edge of impact site were observed 12 h postinjury
(p.i.). Significant leukocyte infiltration and hemorrhage
were already observed on day 1. At day 4 post-TBI, a
lesioned cavity together with its surrounding perilesional
tissue loss was formed under the impact areas. At the
lesional areas, most tissue was lost, no neurons remained,
and leukocyte infiltration together with hemorrhage
appeared. In the perilesional areas, selective neuron
Figure 2 The time course of parenchymal connective tissue
growth factor+ (CTGF+) non-neuron cell accumulation in traumatic
brain injury. The numbers of CTGF+ cells of every rat brain were
counted in eight high-power fields. We only counted positive cells
with the nucleus at the focal plane. Results are presented as arithmetic
means of positive cells per high-power field and SEM. Statistical
analysis was carried out using one-way analysis of variance, followed
by Dunnett’s multiple comparison test (GraphPad Prism 4.0 Software).
**P < 0.01 compared with the normal control.
Liu et al. Diagnostic Pathology 2014, 9:141 Page 3 of 5
http://www.diagnosticpathology.org/content/9/1/141loss with leukocyte infiltration was observed. In the
subcortical white matter, no morphological changes
were observed.
The expression of CTGF post-TBI was studied using
immunohistochemistry. In normal adult rat brain, CTGF
immunoreactivity was rarely observed in the cortex and
meningeal (0.20 ± 0.194 per high-power field, Figures 1A
and 2), only a few CTGF immunoreactivity was demon-
strated in small vessels (Figure 1A, box indicated).
Furthermore, almost all ependymal cells showed CTGF+
(Figure 1B). After TBI, no visible change in CTGF
immunoreactivity was detected in the contralateral
hemisphere (data not shown). In the injured (ipsilateral)
sides, we found that CTGF expression in neurons did not
change significantly, but the accumulation of non-neuron
CTGF+ cells was observed in the lesion and perilesional
areas (Figure 1C, arrows indicated). We then quantified
the non-neuron CTGF+ cells in lesional areas. CTGF+
neurons were not counted. After TBI, a slight increase
in CTGF+ non-neuron cells was observed confined to
the lesion as early as 6 h p.i. (0.50 ± 0.497 per high-power
field, P > 0.05, Figures 1D and 2). The accumulation of
CTGF+ non-neuron cells increased over time (Figures 1E,
F and 2). The accumulation of CTGF+ non-neuron cellsFigure 1 Accumulation of connective tissue growth factor+ (CTGF+) non-neuron cells in traumatic brain injury. A: In normal brains, CTGF
immunoreactivity was occasionally observed in the brain tissue. The boxed area indicates CTGF immunoreactivity in small vessels. B: Almost all
ependymal cells showed CTGF+. C-H: The accumulation of CTGF+ cells in the lesioned regions at 18 h (C), 6 h (D), 24 h (E), 48 h (F), 72 h (G) and 96 h (H).
Arrows indicate the accumulation of CTGF+ non-neuron cells with astrocytes phenotype in the cortex and meningeal (C). CTGF immunoreactivity was also
detected in endothelial cells (F). A significant increase in CTGF+ non-neuron cells was observed confined to the lesion at 72 h postinjury (G). The boxed
area indicates the localization of CTGF+ non-neuron cells that were mainly identified as astrocytes with typical stellate morphologic characteristics or
belt-shaped, grouped pattern. The accumulation of CTGF+ non-neuron cells reached the maximum at 96-h postinjury (H). Scale bars are 50 μm.
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high-power field, P < 0.01, Figures 1G and 2) and reached
the maximum at 96-h post-TBI (74.20 ± 7.248, P < 0.01,
Figures 1H and 2) during our observed time period.
The accumulation of CTGF+ non-neuron cells was
mainly in perilesional areas but not in remote areas of
the ipsilateral and contralateral hemispheres. At the
lesioned site, most of the CTGF+ non-neuron cells showed
activated astrocytes phenotypes with typical stellate mor-
phologic characteristics or belt-shaped, grouped pattern
(Figure 1G, box indicated). CTGF immunoreactivity
was also detected in endothelial cells (Figure 1F, arrows
indicated), but no significant differences were observed
between injured and control brains.
Discussion
Here we analyzed the accumulation of CTGF+ non-neuron
cells in rat brain of weight-drop contusion following TBI.
Significant CTGF+ non-neuron cell accumulation was
detected 72-h p.i. and increased markedly. The CTGF+
non-neuron cells mainly detected in perilesioned areas
where CTGF accumulation various in different time course.
Furthermore, most CTGF+ non-neuron cells showed
activated astrocyte phenotypes with typical stellate mor-
phologic characteristics.
Nowadays, increasingly studies are focusing on the
recovery stage after neural tissue injury [14], through
which more pro-recovering molecules are discovered
[15]. CTGF is investigated as a secreted cell matrix-
inducing peptide involved in both tissue regeneration
mechanisms [3]. In normal rat brains, CTGF expression
can be found in glia-like cells, neurons, endothelial cells
and ependymal cells [6]. In the CNS, increased expression
of CTGF was induced under certain pathological condi-
tions, such as spinal cord injury and cerebral infarction
[6,16]. It was demonstrated that in kainic acid-induced
brain injury, significantly increasing of CTGF mRNA
expression was limited in the ipsilateral hippocampus, no
CTGF protein expression was observed in non-lesioned
hippocampus [16]. However, in the current investigation,
using an open-skull weight-drop injury, which is consid-
ered to cause less learning and memory deficits and
produce less degenerating neurons compared with kainic
acid-induced brain injury model [17], the accumulation
of non-neuron CTGF+ cells was not only in the direct
vicinity of the lesion core, but also in cells with astrocyte
phenotypes which located on non-lesioned areas.
Accumulation of CTGF+ astrocytes is a well-established
response to traumatic brain injury, which contributes to
wound healing and glial scar formation, and is beneficial
for TBI recovery [16]. Reactive CTGF+ cells with astrocyte
phenotypes accumulated rapidly after TBI. In 6-h p.i.,
CTGF+ cells with astrocyte phenotypes accumulated in
the direct vicinity of the lesion core in the cortex, while asearly as 6 h p.i., CTGF+ cells with parenchymal astrocyte
phenotypes was detected in the non-lesioned areas. These
results suggest a participation of CTGF in the pathological
features within the astrocytic compartment. Glial/collagen
scarring is composed of dense packed reactive astrocytes
and matrix protein deposition sealed by formation of a
new basal lamina. Hence, the restricted expression and
accumulation of CTGF in TBI adds convincing evidence
for the participation of CTGF in the early astrocytic CNS
injury response as a key molecule contributing to TBI
recovery.
Conclusion
We have found an early accumulation of CTGF+ cells in
open-skull weight-drop-induced TBI. Our study suggests
that CTGF expression might define a subtype of activated
astrocytes with a specific role in the tissue-repair pro-
cesses following TBI.
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